What is the current Vitaspring Biomedical Co. market capitalization?
The current market capitalization of Vitaspring Biomedical Co. is 3.09 B USD.
Vitaspring Biomedical Co. Market capitalization 2024
Vitaspring Biomedical Co. Market capitalization
3.09 B USD
Ticker
VSBC
ISIN
US92851B1026
In 2024, Vitaspring Biomedical Co.'s market cap stood at 3.09 B USD, a 0% increase from the 0 USD market cap in the previous year.
The Vitaspring Biomedical Co. Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2022 | 3.09 |
| 2021 | 1.29 |
| 2020 | 0.34 |
| 2019 | 0.1 |
| 2018 | - |
| 2017 | - |
Vitaspring Biomedical Co. Aktienanalyse
What does Vitaspring Biomedical Co. do?
Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Vitaspring Biomedical Co.'s Market Capitalization
Vitaspring Biomedical Co.'s market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Vitaspring Biomedical Co.'s market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Vitaspring Biomedical Co.'s market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Vitaspring Biomedical Co.’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Vitaspring Biomedical Co. stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Vitaspring Biomedical Co..
How has the market capitalization of Vitaspring Biomedical Co. developed in recent years?
The market capitalization of Vitaspring Biomedical Co. has increased/decreased by 0% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Vitaspring Biomedical Co.?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Vitaspring Biomedical Co.?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Vitaspring Biomedical Co. have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Vitaspring Biomedical Co. pay?
Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.
What is the dividend yield of Vitaspring Biomedical Co.?
The current dividend yield of Vitaspring Biomedical Co. is .
When does Vitaspring Biomedical Co. pay dividends?
Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Vitaspring Biomedical Co.?
Vitaspring Biomedical Co. paid dividends every year for the past 0 years.
What is the dividend of Vitaspring Biomedical Co.?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vitaspring Biomedical Co. located?
Vitaspring Biomedical Co. is assigned to the '-' sector.
Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vitaspring Biomedical Co. from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.
When did Vitaspring Biomedical Co. pay the last dividend?
The last dividend was paid out on 12/19/2024.
What was the dividend of Vitaspring Biomedical Co. in the year 2023?
In the year 2023, Vitaspring Biomedical Co. distributed 0 USD as dividends.
In which currency does Vitaspring Biomedical Co. pay out the dividend?
The dividends of Vitaspring Biomedical Co. are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Vitaspring Biomedical Co.
Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Vitaspring Biomedical Co. Revenue
- Vitaspring Biomedical Co. Net Income
- Vitaspring Biomedical Co. P/E
- Vitaspring Biomedical Co. P/S
- Vitaspring Biomedical Co. EBIT
- Vitaspring Biomedical Co. Dividend
- Vitaspring Biomedical Co. Stocks
- Vitaspring Biomedical Co. Market capitalization
- Vitaspring Biomedical Co. Debt
- Vitaspring Biomedical Co. Liabilities
- Vitaspring Biomedical Co. Equity
- Vitaspring Biomedical Co. AAQS
- Vitaspring Biomedical Co. Employees
- Vitaspring Biomedical Co. ROE
- Vitaspring Biomedical Co. ROA
- Vitaspring Biomedical Co. ROCE